In this regard, Filardo et al. [60] studied REα and GPR30 expression in breast cancer through immunohistochemistry, observing that of a total of 321 tumor tissues analyzed, approximately 60% expressed only GPR30 and 40% both receptors. The gene discussed is GPER1; the disease is breast cancer.